Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Nutraceuticals in heart failure patients: A systematic review.

Hopper I, Connell C, Briffa T, Depasquale CG, Driscoll A, Kistler PM, Macdonald PS, Sindone A, Thomas L, Atherton JJ.

J Card Fail. 2019 Nov 5. pii: S1071-9164(19)30715-8. doi: 10.1016/j.cardfail.2019.10.014. [Epub ahead of print] Review.

PMID:
31704198
2.

The potential prognostic utility of salivary galectin-3 concentrations in heart failure.

Zhang X, Karunathilaka N, Senanayake S, Subramaniam VN, Chan W, Kostner K, Fraser J, Atherton JJ, Punyadeera C.

Clin Res Cardiol. 2019 Oct 9. doi: 10.1007/s00392-019-01557-0. [Epub ahead of print]

PMID:
31598750
3.

Echocardiographic predictors of all-cause mortality in patients with left ventricular ejection fraction >35%: Value of guideline based assessment of diastolic dysfunction.

Prasad SB, Guppy-Coles KB, Holland D, Stanton T, Krishnasamy R, Whalley G, Atherton JJ, Thomas L.

Int J Cardiol Heart Vasc. 2019 Aug 3;24:100407. doi: 10.1016/j.ijcha.2019.100407. eCollection 2019 Sep.

4.

Response to "Paradise Lost? New National Heart Foundation of Australia Guidelines on Heart Failure Fail to Recognise the Intensity of Exercise Evidence".

Briffa T, Atherton JJ, Connell C.

Heart Lung Circ. 2019 Jul 11. pii: S1443-9506(19)31350-2. doi: 10.1016/j.hlc.2019.06.721. [Epub ahead of print] No abstract available.

PMID:
31320257
5.

Accuracy of Cardiac Nurse Acquired and Measured Three-Dimensional Echocardiographic Left Ventricular Ejection Fraction: Comparison to Echosonographer.

Guppy-Coles KB, Prasad SB, Smith KC, Lo A, Beard P, Ng A, Atherton JJ.

Heart Lung Circ. 2019 Apr 26. pii: S1443-9506(19)30347-6. doi: 10.1016/j.hlc.2019.04.008. [Epub ahead of print]

PMID:
31320256
6.

Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

Deed G, Atherton JJ, d'Emden M, Rasalam R, Sharma A, Sindone A.

Diabetes Ther. 2019 Oct;10(5):1625-1643. doi: 10.1007/s13300-019-0663-x. Epub 2019 Jul 10. Review.

7.

Relation of Left Atrial Volumes in Patients With Myocardial Infarction to Left Ventricular Filling Pressures and Outcomes.

Prasad SB, Guppy-Coles K, Stanton T, Armstrong J, Krishnaswamy R, Whalley G, Atherton JJ, Thomas L.

Am J Cardiol. 2019 Aug 1;124(3):325-333. doi: 10.1016/j.amjcard.2019.05.007. Epub 2019 May 9.

PMID:
31151655
8.

New Diastology Guidelines: Evolution, Validation and Impact on Clinical Practice.

Prasad SB, Holland DJ, Atherton JJ, Whalley G.

Heart Lung Circ. 2019 Sep;28(9):1411-1420. doi: 10.1016/j.hlc.2019.03.013. Epub 2019 Apr 24. Review.

PMID:
31064714
9.

The continuous heart failure spectrum: moving beyond an ejection fraction classification.

Triposkiadis F, Butler J, Abboud FM, Armstrong PW, Adamopoulos S, Atherton JJ, Backs J, Bauersachs J, Burkhoff D, Bonow RO, Chopra VK, de Boer RA, de Windt L, Hamdani N, Hasenfuss G, Heymans S, Hulot JS, Konstam M, Lee RT, Linke WA, Lunde IG, Lyon AR, Maack C, Mann DL, Mebazaa A, Mentz RJ, Nihoyannopoulos P, Papp Z, Parissis J, Pedrazzini T, Rosano G, Rouleau J, Seferovic PM, Shah AM, Starling RC, Tocchetti CG, Trochu JN, Thum T, Zannad F, Brutsaert DL, Segers VF, De Keulenaer GW.

Eur Heart J. 2019 Jul 1;40(26):2155-2163. doi: 10.1093/eurheartj/ehz158.

PMID:
30957868
10.

Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study.

Grover S, Lloyd R, Perry R, Lou PW, Haan E, Yeates L, Woodman R, Atherton JJ, Semsarian C, Selvanayagam JB.

Eur Heart J Cardiovasc Imaging. 2019 Aug 1;20(8):932-938. doi: 10.1093/ehjci/jey220.

PMID:
30668650
11.

Diastolic Dysfunction Assessed Using Contemporary Guidelines and Prognosis Following Myocardial Infarction.

Prasad SB, Lin AK, Guppy-Coles KB, Stanton T, Krishnasamy R, Whalley GA, Thomas L, Atherton JJ.

J Am Soc Echocardiogr. 2018 Oct;31(10):1127-1136. doi: 10.1016/j.echo.2018.05.016. Epub 2018 Aug 7.

PMID:
30097298
12.

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018.

NHFA CSANZ Heart Failure Guidelines Working Group, Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, Kistler PM, Briffa T, Wong J, Abhayaratna W, Thomas L, Audehm R, Newton P, O'Loughlin J, Branagan M, Connell C.

Heart Lung Circ. 2018 Oct;27(10):1123-1208. doi: 10.1016/j.hlc.2018.06.1042. No abstract available.

13.

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018.

Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, Kistler P, Briffa TG, Wong J, Abhayaratna WP, Thomas L, Audehm R, Newton PJ, O'Loughlin J, Connell C, Branagan M.

Med J Aust. 2018 Oct 15;209(8):363-369. Epub 2018 Aug 2.

PMID:
30067937
14.

Diastolic stress echocardiography: from basic principles to clinical applications.

Prasad SB, Holland DJ, Atherton JJ.

Heart. 2018 Nov;104(21):1739-1748. doi: 10.1136/heartjnl-2017-312323. Epub 2018 Jul 20. Review.

PMID:
30030333
15.

Differences in management and outcomes for men and women with ST-elevation myocardial infarction.

Khan E, Brieger D, Amerena J, Atherton JJ, Chew DP, Farshid A, Ilton M, Juergens CP, Kangaharan N, Rajaratnam R, Sweeny A, Walters DL, Chow CK.

Med J Aust. 2018 Aug 6;209(3):118-123. Epub 2018 Jul 23.

PMID:
30025513
16.

Addition of Supervised Exercise Training to a Post-Hospital Disease Management Program for Patients Recently Hospitalized With Acute Heart Failure: The EJECTION-HF Randomized Phase 4 Trial.

Mudge AM, Denaro CP, Scott AC, Meyers D, Adsett JA, Mullins RW, Suna JM, Atherton JJ, Marwick TH, Scuffham P, O'Rourke P.

JACC Heart Fail. 2018 Feb;6(2):143-152. doi: 10.1016/j.jchf.2017.11.016.

17.

TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.

Chow CK, Thiagalingam A, Santo K, Kok C, Thakkar J, Stepien S, Billot L, Jan S, Joshi R, Hillis GS, Brieger D, Chew DP, Rådholm K, Atherton JJ, Bhindi R, Collins N, Coverdale S, Hamilton-Craig C, Kangaharan N, Maiorana A, McGrady M, Shetty P, Thompson P, Rogers A, Redfern J.

BMJ Open. 2018 Jan 27;8(1):e019463. doi: 10.1136/bmjopen-2017-019463.

18.

Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study.

McDonald K, Troughton R, Dahlström U, Dargie H, Krum H, van der Meer P, McDonagh T, Atherton JJ, Kupfer K, San George RC, Richards M, Doughty R.

Eur J Heart Fail. 2018 Mar;20(3):474-480. doi: 10.1002/ejhf.1053. Epub 2018 Jan 4.

19.

Identification and Validation of a Salivary Protein Panel to Detect Heart Failure Early.

Zhang X, Walsh T, Atherton JJ, Kostner K, Schulz B, Punyadeera C.

Theranostics. 2017 Sep 26;7(18):4350-4358. doi: 10.7150/thno.21727. eCollection 2017.

20.

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.

Montvida O, Shaw J, Atherton JJ, Stringer F, Paul SK.

Diabetes Care. 2018 Jan;41(1):69-78. doi: 10.2337/dc17-1414. Epub 2017 Nov 6.

PMID:
29109299
21.

Expert Comment: Is Medication Titration in Heart Failure too Complex?

Atherton JJ, Hickey A.

Card Fail Rev. 2017 Apr;3(1):25-32. doi: 10.15420/cfr.2017:1:2.

22.

Position Statement on the Diagnosis and Management of Familial Dilated Cardiomyopathy.

Fatkin D, Johnson R, McGaughran J, Weintraub RG, Atherton JJ; CSANZ Genetics Council Writing Group.

Heart Lung Circ. 2017 Nov;26(11):1127-1132. doi: 10.1016/j.hlc.2017.04.021. Epub 2017 Jun 7. No abstract available.

PMID:
28655534
23.

Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.

Ingles J, Burns C, Bagnall RD, Lam L, Yeates L, Sarina T, Puranik R, Briffa T, Atherton JJ, Driscoll T, Semsarian C.

Circ Cardiovasc Genet. 2017 Apr;10(2). pii: e001620. doi: 10.1161/CIRCGENETICS.116.001620.

24.

Myofibrillar Cardiomyopathy due to a Novel Desmin Gene Mutation: Complementary Role of Echocardiography, Cardiac Magnetic Resonance, and Genetic Testing in Delineating Diagnosis.

Koitka K, Dahiya A, Lo A, Scalia GM, Atherton JJ, Prasad SB.

CASE (Phila). 2017 Feb 27;1(1):28-33. doi: 10.1016/j.case.2016.11.001. eCollection 2017 Feb.

25.

Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial.

Wu CJ, Atherton JJ, MacIsaac RJ, Courtney M, Chang AM, Thompson DR, Kostner K, MacIsaac AI, d'Emden M, Graves N, McPhail SM.

BMC Health Serv Res. 2017 Feb 2;17(1):109. doi: 10.1186/s12913-017-2043-4.

26.

Characteristics of patients with haematological and breast cancer (1996-2009) who died of heart failure-related causes after cancer therapy.

Versace VL, Berry NM, Chowdhury MH, Ullah S, McCarthy AL, Atherton JJ, Koczwara B, Roder D, Clark RA.

ESC Heart Fail. 2016 Dec;3(4):253-260. Epub 2016 Jul 17.

27.

Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis.

Clark RA, Berry NM, Chowdhury MH, McCarthy AL, Ullah S, Versace VL, Atherton JJ, Koczwara B, Roder D.

Intern Med J. 2016 Nov;46(11):1297-1306. doi: 10.1111/imj.13201.

PMID:
27502031
28.

Improving medication titration in heart failure by embedding a structured medication titration plan.

Hickey A, Suna J, Marquart L, Denaro C, Javorsky G, Munns A, Mudge A, Atherton JJ.

Int J Cardiol. 2016 Dec 1;224:99-106. doi: 10.1016/j.ijcard.2016.09.001. Epub 2016 Sep 7.

PMID:
27643473
29.

A pilot study to demonstrate diagnostic potential of galectin-3 levels in saliva.

Zhang X, Wan Y, Chata R, Brazzale A, Atherton JJ, Kostner K, Dimeski G, Punyadeera C.

J Clin Pathol. 2016 Dec;69(12):1100-1104. doi: 10.1136/jclinpath-2016-203631. Epub 2016 Jun 23.

PMID:
27340130
30.
31.

Right Ventricular Systolic Dysfunction Is Common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa.

Ojji DB, Lecour S, Atherton JJ, Blauwet LA, Alfa J, Sliwa K.

PLoS One. 2016 Apr 13;11(4):e0153479. doi: 10.1371/journal.pone.0153479. eCollection 2016.

32.

The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women.

O'Neil A, Fisher AJ, Kibbey KJ, Jacka FN, Kotowicz MA, Williams LJ, Stuart AL, Berk M, Lewandowski PA, Atherton JJ, Taylor CB, Pasco JA.

Prev Med. 2016 Jun;87:115-120. doi: 10.1016/j.ypmed.2016.02.028. Epub 2016 Feb 22.

PMID:
26906397
33.

Risk-Factor Profile and Comorbidities in 2398 Patients With Newly Diagnosed Hypertension From the Abuja Heart Study.

Ojji DB, Libhaber E, Atherton JJ, Abdullahi B, Nwankwo A, Sliwa K.

Medicine (Baltimore). 2015 Sep;94(39):e1660. doi: 10.1097/MD.0000000000001660.

34.

Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.

Gramlich M, Pane LS, Zhou Q, Chen Z, Murgia M, Schötterl S, Goedel A, Metzger K, Brade T, Parrotta E, Schaller M, Gerull B, Thierfelder L, Aartsma-Rus A, Labeit S, Atherton JJ, McGaughran J, Harvey RP, Sinnecker D, Mann M, Laugwitz KL, Gawaz MP, Moretti A.

EMBO Mol Med. 2015 May;7(5):562-76. doi: 10.15252/emmm.201505047.

35.

Hierarchical layered double hydroxide nanocomposites: structure, synthesis and applications.

Gu Z, Atherton JJ, Xu ZP.

Chem Commun (Camb). 2015 Feb 21;51(15):3024-36. doi: 10.1039/c4cc07715f. Review.

PMID:
25562489
36.

A multimarker approach to diagnose and stratify heart failure.

Wan Y, Xhang X, Atherton JJ, Kostner K, Dimeski G, Punyadeera C.

Int J Cardiol. 2015 Feb 15;181:369-75. doi: 10.1016/j.ijcard.2014.12.052. Epub 2014 Dec 23.

PMID:
25555282
37.

Evaluation of training nurses to perform semi-automated three-dimensional left ventricular ejection fraction using a customised workstation-based training protocol.

Guppy-Coles KB, Prasad SB, Smith KC, Hillier S, Lo A, Atherton JJ.

J Clin Nurs. 2015 Jun;24(11-12):1479-88. doi: 10.1111/jocn.12666. Epub 2014 Sep 25.

PMID:
25256918
38.

Long-term efficacy of a tele-health intervention for acute coronary syndrome patients with depression: 12-month results of the MoodCare randomized controlled trial.

O'Neil A, Taylor B, Hare DL, Sanderson K, Cyril S, Venugopal K, Chan B, Atherton JJ, Hawkes A, Walters DL, Oldenburg B; MoodCare Investigator Team.

Eur J Prev Cardiol. 2015 Sep;22(9):1111-20. doi: 10.1177/2047487314547655. Epub 2014 Aug 26.

PMID:
25159700
39.

Efficacy and feasibility of a tele-health intervention for acute coronary syndrome patients with depression: results of the "MoodCare" randomized controlled trial.

O'Neil A, Taylor B, Sanderson K, Cyril S, Chan B, Hawkes AL, Hare DL, Jelinek M, Venugopal K, Atherton JJ, Amerena J, Grigg L, Walters DL, Oldenburg B; MoodCare Investigator Team.

Ann Behav Med. 2014 Oct;48(2):163-74. doi: 10.1007/s12160-014-9592-0.

PMID:
24570217
40.

Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients.

Hawkes AL, Patrao TA, Ware R, Atherton JJ, Taylor CB, Oldenburg BF.

BMC Cardiovasc Disord. 2013 Sep 10;13:69. doi: 10.1186/1471-2261-13-69.

41.

Cardiac myosin-binding protein C gene mutation expressed as hypertrophic cardiomyopathy and left ventricular noncompaction within two families: insights from cardiac magnetic resonance in clinical screening: Camuglia MYBPC3 gene mutation and MRI.

Camuglia AC, Younger JF, McGaughran J, Lo A, Atherton JJ.

Int J Cardiol. 2013 Oct 3;168(3):2950-2. doi: 10.1016/j.ijcard.2013.03.168. Epub 2013 Apr 30. No abstract available.

PMID:
23642604
42.

Telephone-delivered health coaching improves anxiety outcomes after myocardial infarction: the 'ProActive Heart' trial.

O'Neil A, Hawkes AL, Atherton JJ, Patrao TA, Sanderson K, Wolfe R, Taylor CB, Oldenburg B.

Eur J Prev Cardiol. 2014 Jan;21(1):30-8. doi: 10.1177/2047487312460515. Epub 2012 Sep 6.

PMID:
22956633
43.

International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation.

Suarez J, Piccini JP, Liang L, Atherton JJ, Hayward CS, Krum H, Fonarow GC, Lopes RD, Hernandez AF.

Am Heart J. 2012 May;163(5):804-11. doi: 10.1016/j.ahj.2012.02.008. Epub 2012 Mar 27.

44.

Stage B heart failure: rationale for screening.

Atherton JJ.

Heart Fail Clin. 2012 Apr;8(2):273-83. doi: 10.1016/j.hfc.2011.11.003. Review.

PMID:
22405666
45.

A lethal injection?

Arumugam D, Atherton JJ, Martin PT.

Lancet. 2012 Feb 4;379(9814):492. doi: 10.1016/S0140-6736(11)61711-X. No abstract available.

PMID:
22305227
46.

Chronic heart failure: we are fighting the battle, but are we winning the war?

Atherton JJ.

Scientifica (Cairo). 2012;2012:279731. doi: 10.6064/2012/279731. Epub 2012 Dec 20. Review.

47.

Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International-Asia Pacific).

Atherton JJ, Hayward CS, Wan Ahmad WA, Kwok B, Jorge J, Hernandez AF, Liang L, Kociol RD, Krum H; ADHERE International–Asia Pacific Scientific Advisory Committee.

J Card Fail. 2012 Jan;18(1):82-8. doi: 10.1016/j.cardfail.2011.09.003. Epub 2011 Oct 8.

PMID:
22196846
48.

Exercise training in recently hospitalized heart failure patients enrolled in a disease management programme: design of the EJECTION-HF randomized controlled trial.

Mudge AM, Denaro CP, Scott AC, Atherton JJ, Meyers DE, Marwick TH, Adsett JA, Mullins RW, Suna JM, Scuffham PA, O'Rourke PK.

Eur J Heart Fail. 2011 Dec;13(12):1370-5. doi: 10.1093/eurjhf/hfr139. Epub 2011 Nov 6.

49.

Striving to achieve best practice in heart failure disease management.

Atherton JJ, Hickey A, Suna J.

BMJ Qual Saf. 2012 Mar;21(3):263. doi: 10.1136/bmjqs-2011-000338. Epub 2011 Sep 22. No abstract available.

PMID:
21949435
50.

The fall and rise of drug-eluting stents.

Hammett CJ, Stewart PJ, Atherton JJ.

Med J Aust. 2011 Aug 1;195(3):110-1. No abstract available.

PMID:
21806525

Supplemental Content

Loading ...
Support Center